Results 51 to 60 of about 411 (100)

Частота алельних варіантів гена матриксного GLA-протеїну (MGP) в українській популяції [PDF]

open access: yes, 2012
Наук.
Mazur, Tetiana Stanislavivna   +2 more
core  

Автореферат - Тенденції професійної підготовки фахівців фармацевтичної галузі в Україні (ХХ – початок ХХІ століття [PDF]

open access: yes, 2018
У дисертації подано авторське тлумачення базових понять дослідження професійної підготовки фахівців фармацевтичної галузі в Україні «тенденції», «професійна підготовка фахівців фармацевтичної галузі».
Сліпчук, Валентина Леонідівна
core  

Клиническая фармакогенетика: тернистый путь внедрения в клиническую практику

open access: yesКачественная клиническая практика, 2018
Один из путей повышения эффективности и безопасности лекарственных средств - персонализированная медицина.

doaj  

APPLIED ASPECTS OF SLCO1B1 PHARMACOGENETIC TESTING FOR PREDICTING OF STATIN-INDUCED MYOPATHY AND PERSONALIZATION OF STATINS THERAPY

open access: yesРациональная фармакотерапия в кардиологии, 2015
The clinical significance of the SLCO1B1 gene polymorphism (encoding an organic anion transport polipeptide) in the development of statin induced myopathy is considered.
D. A. Sychev   +2 more
doaj   +1 more source

EVALUATION OF SENSITIVITY TO CLOPIDOGREL: THE CURRENT STATE OF THE PROBLEM

open access: yesАтеротромбоз, 2015
The review deals with the laboratory assessment of clopidogrel effect in patients with CHD. The article presents the results of major studies that have demonstrated the relationship between the residual platelet reactivity level and drug pharmacogenetics
A. L. Komarov
doaj   +1 more source

Pharmacogenetic testing: current state of the issue [PDF]

open access: yes
Aim. The purpose of this work is to emphasize the importance and practical benefits of pharmacogenetics in medicine, demonstrating how the integration of pharmacogenetics into clinical practice can improve treatment outcomes and enhance the safety of ...
O. O. Kremzer   +2 more
core   +2 more sources

PREVALENCE OF POLYMORPHOUS LOCUS 681G>A OF CYP2C19 GENE IN RUSSIAN POPULATION

open access: yesActa Biomedica Scientifica, 2014
The prevalence of genotypes and alleles of polymorphous locus 681G>A of CYP2C19 gene in Russian population of Eastern Siberia. We conducted comparative analysis of response characteristics with previous data of other world's populations.
T. A. Bairova   +3 more
doaj  

THE SIGNIFICANCE OF PHARMACOGENETIC CYP2C19 TESTING FOR PERSONALIZATION OF THE ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE

open access: yesРациональная фармакотерапия в кардиологии, 2015
The clinical significance  of CYP2C19 genetic polymorphism, associated with the violation of the formation of the active clopidogrel metabolite, for efficacy and safety of this drug in cardiology practice is discussed.
K. B. Mirzaev   +3 more
doaj   +1 more source

Clinical and genetic characteristics of treatment-resistant asthma

open access: yesМедицинский совет, 2013
Therapy resistant asthma (TRA) is most difficult to treat and its course is least predictable. TRA remains least studied despite the fact that its many mechanisms have been detected.
V. I. Trofimov, G. A. Mironova
doaj   +1 more source

Pharmacogenetics of 6-mercaptopurine and methotrexate in childhood acute lymphoblastic leukemia [PDF]

open access: yes, 2015
Farmakogenomika proučava odnos između genetičkog sklopa individue i njegovog odgovora na lekove i jedan je od stubova personalizovane medicine. Dosadašnji princip lečenja da se standardna doza leka daje svim pacijentima sa istom dijagnozom po unapred ...
Kotur, Nikola M.
core  

Home - About - Disclaimer - Privacy